TNON vs. ALUR, NEPH, RVP, OSRH, QTI, CLGN, NXGL, IRIX, PETV, and NXL
Should you be buying Tenon Medical stock or one of its competitors? The main competitors of Tenon Medical include Allurion Technologies (ALUR), Nephros (NEPH), Retractable Technologies (RVP), OSR (OSRH), QT Imaging (QTI), CollPlant Biotechnologies (CLGN), NEXGEL (NXGL), IRIDEX (IRIX), PetVivo (PETV), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.
Tenon Medical vs.
Tenon Medical (NASDAQ:TNON) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.
Allurion Technologies has a net margin of -71.24% compared to Tenon Medical's net margin of -413.88%. Allurion Technologies' return on equity of 0.00% beat Tenon Medical's return on equity.
22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 4.7% of Tenon Medical shares are owned by insiders. Comparatively, 22.4% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Allurion Technologies had 6 more articles in the media than Tenon Medical. MarketBeat recorded 6 mentions for Allurion Technologies and 0 mentions for Tenon Medical. Allurion Technologies' average media sentiment score of 0.53 beat Tenon Medical's score of 0.00 indicating that Allurion Technologies is being referred to more favorably in the news media.
Tenon Medical has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.58, meaning that its share price is 158% less volatile than the S&P 500.
Allurion Technologies received 1 more outperform votes than Tenon Medical when rated by MarketBeat users. However, 100.00% of users gave Tenon Medical an outperform vote while only 72.73% of users gave Allurion Technologies an outperform vote.
Tenon Medical presently has a consensus target price of $4.67, indicating a potential upside of 312.98%. Allurion Technologies has a consensus target price of $22.83, indicating a potential upside of 705.12%. Given Allurion Technologies' higher possible upside, analysts clearly believe Allurion Technologies is more favorable than Tenon Medical.
Tenon Medical has higher earnings, but lower revenue than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Allurion Technologies beats Tenon Medical on 11 of the 18 factors compared between the two stocks.
Get Tenon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TNON and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tenon Medical Competitors List
Related Companies and Tools
This page (NASDAQ:TNON) was last updated on 5/22/2025 by MarketBeat.com Staff
